GPX4 and glioblastoma: Indeed, GPX4 expression was dramatically decreased after ALZ003 treatment in the dose-dependent manner in TMZ-sensitive and –resistant glioblastoma (Fig. 5B and Supplementary Fig. S4B), suggesting that ALZ003-mediated ROS accumulation is caused by the downregulation of GPX4.